[Current medical treatment of inflammatory bowel disease].
Bosques-Padilla
Francisco
F
Facultad de Medicina, UANL, Monterrey, N.L. México.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000636:Aminosalicylic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D003093:Colitis, Ulcerative / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D003424:Crohn Disease / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine